Lower Silesia Cardiogenic Shock Initiative

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-60
SponsorWroclaw Medical University

About this trial

LSCSI is a Hub\&Spoke project with the main aim to improve the outcome of patients with cardiogenic shock in Lower Silesia region, Poland. It consists of one "hub" which is Wroclaw University Hospital and eleven "spokes" which are eleven cardiology departments situated in Lower Silesian Voivodeship. The consortium have unified protocol defining which cardiogenic shock patient and when should be transferred to the "hub" for enhanced treatment options including durable mechanical circulatory support or heart transplant. The "hub" have 7/24 Shock Team on-site supplied with a protocol how to proceed with "spoke" transferred patients including decision making on which mechanical circulatory support implant with subsequent de-escalation or escalation pathway.

Eligibility criteria

Qualifiers

Fulfilled definition of cardiogenic shock

Age 18 - 60 years

Shock duration below 24 hours

Disqualifiers

History of cardiac arrest with anoxemic brain injury

Irreversible multiorgan failure

End stage of chronic diseases other than heart failure

Neoplastic disease

Trial design

Treatments tested in this trial

  • Structured treatment of cardiogenic shock patients

Treatment groups

No treatment groups listed

Sponsors and collaborators